News
Prioritize COVID-19 vaccination in both types of diabetes, say docs
December 9, 2020
The study is the first to prospectively evaluate COVID-19 severity factors and death in people with type 1 and type 2 diabetes separately.
News
Diabetic retinopathy may predict greater risk of COVID-19 severity
December 3, 2020
“Our study reports the first description of diabetic retinopathy as a potential risk factor for poor COVID-19 outcomes,” said the authors of a new study.
News
Patient health suffers amid pandemic health care shortages
December 1, 2020
More than half of clinician respondents to a survey said they saw a decline in patient health because of delayed or inaccessible care.
News
First-of-its kind guideline on lipid monitoring in endocrine diseases
November 6, 2020
A new guideline from the Endocrine Society calls for heightened awareness of cholesterol management and treatment in endocrine diseases beyond diabetes; the aim is to make lipid panel routine in assessment.
News
Consensus guidelines address inpatient diabetes technology
October 29, 2020
The comprehensive document aimed at clinicians, hospitals, and researchers covers use of both continuous glucose monitors and automated insulin dosing systems in the hospital setting.
News
COVID-19 antibody response not reduced with diabetes
October 20, 2020
Findings provide “cautious optimism” that a COVID-19 vaccine would be expected to work as well in people with diabetes as those without.
News
Entresto halves renal events in preserved EF heart failure patients
October 15, 2020
The PARAGON-HF trial of sacubitril/valsartan in patients with heart failure with preserved ejection fraction didn’t meet its primary outcome but significantly improved a secondary renal endpoint.
![1]()
News
Empagliflozin cut PA pressures in heart failure patients
October 12, 2020
The drops in pulmonary artery pressure were modest but large enough to be clinically meaningful, they appeared quickly, and increased over time.
![1]()
News
EMPEROR-Reduced: Empagliflozin’s HFrEF benefit holds steady on top of sacubitril/valsartan
October 6, 2020
Empagliflozin treatment of HFrEF was equally beneficial regardless of whether patients also received sacubitril/valsartan.
![1]()
News
Dapagliflozin’s CKD performance sends heart failure messages
October 5, 2020
The recently reported DAPA-CKD trial results focused on patients with renal disease, but the findings also resonate for heart failure clinicians.
